# REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study

> **NCT06987214** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Bronchiectasis Adult

## Interventions

- **BIOLOGICAL:** REGEND001 Autologous Basal Layer Stem Cell Suspension

## Key facts

- **NCT ID:** NCT06987214
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06987214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06987214, "REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06987214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*